1012 Health related quality of life of mothers of children with cancer: The role of social support and social capital (English)
- New search for: Nicolaou, C.
- New search for: Kouta, C.
- New search for: Papathanasoglou, E.
- New search for: Middleton, N.
- New search for: Nicolaou, C.
- New search for: Kouta, C.
- New search for: Papathanasoglou, E.
- New search for: Middleton, N.
In:
European journal of cancer
;
51
;
S149
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:1012 Health related quality of life of mothers of children with cancer: The role of social support and social capital
-
Contributors:Nicolaou, C. ( author ) / Kouta, C. ( author ) / Papathanasoglou, E. ( author ) / Middleton, N. ( author )
-
Published in:European journal of cancer ; 51 ; S149
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2015-01-01
-
Size:S149
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 51
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancerGonzalez-Vallinas, M. / Vargas, T. / Moreno-Rubio, J. / Molina, S. / Herranz, J. / Cejas, P. / Burgos, E. / Aguayo, C. / Custodio, A. et al. | 2015
- 9
-
High expression of the cysteine proteinase legumain in colorectal cancer - Implications for therapeutic targetingHaugen, M.H. / Boye, K. / Nesland, J.M. / Pettersen, S.J. / Egeland, E.V. / Tamhane, T. / Brix, K. / Maelandsmo, G.M. / Flatmark, K. et al. | 2015
- 18
-
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapyRuff, P. / Ferry, D.R. / Lakom, R. / Prausova, J. / Van Hazel, G.A. / Hoff, P.M. / Cunningham, D. / Arnold, D. / Schmoll, H.J. et al. | 2015
- 27
-
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancerBergmann, L. / Maute, L. / Heil, G. / Russel, J. / Weidmann, E. / Koberle, D. / Fuxius, S. / Weigang-Kohler, K. / Aulitzky, W.E. et al. | 2015
- 37
-
Identification of subjects at risk of proximal advanced neoplasia for colorectal cancer screeningWong, M.C.S. / Ching, J.Y.L. / Chan, V.C.W. / Lam, T.Y.T. / Luk, A.K.C. / Wong, S.H. / Ng, S.C. / Ng, S.S.M. / Wu, J.C.Y. et al. | 2015
- 45
-
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2Oudard, S. / Culine, S. / Vano, Y. / Goldwasser, F. / Theodore, C. / Nguyen, T. / Voog, E. / Banu, E. / Vieillefond, A. et al. | 2015
- 55
-
Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: A stabilisation of an epidemic of viral induced carcinoma?Nasman, A. / Nordfors, C. / Holzhauser, S. / Vlastos, A. / Tertipis, N. / Hammar, U. / Hammarstedt-Nordenvall, L. / Marklund, L. / Munck-Wikland, E. et al. | 2015
- 62
-
Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literatureDel Fabbro, M. / Gallesio, G. / Mozzati, M. et al. | 2015
- 75
-
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapyLartigue, L. / Neuville, A. / Lagarde, P. / Brulard, C. / Rutkowski, P. / Tos, P.D. / Wardelmann, E. / Debiec-Rychter, M. / Italiano, A. et al. | 2015
- 84
-
The Collaborative Wilms Tumour Africa Project; Baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan AfricaPaintsil, V. / David, H. / Kambugu, J. / Renner, L. / Kouya, F. / Eden, T. / Hesseling, P. / Molyneux, E. / Israels, T. et al. | 2015
- 92
-
Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphomaEl-Mallawany, N.K. / Day, N. / Ayello, J. / Van de Ven, C. / Conlon, K. / Fermin, D. / Basrur, V. / Elenitoba-Johnson, K. / Lim, M. et al. | 2015
- 101
-
Evaluation of data quality in the National Prostate Cancer Register of SwedenTomic, K. / Sandin, F. / Wigertz, A. / Robinson, D. / Lambe, M. / Stattin, P. et al. | 2015
- 112
-
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: A new hypothesis based on historical in vitro fertilisation treatment dataOMEGA-project group / Krul, I.M. / Groeneveld, E. / Spaan, M. / van den Belt-Dusebout, A.W. / Mooij, T.M. / Hauptmann, M. / Twisk, J.W.R. / Lambers, M.J. et al. | 2015
- 121
-
The dramatic story of breast cancer in Iran: A reflection of the dangerous lifestyles from the glamorous WestDalfardi, B. et al. | 2015
- 127
-
Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients' and professionals' expertise - A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of CancerSoft Tissue and Bone Sarcoma Group initiativeDesmoid Working Group / Kasper, B. / Baumgarten, C. / Bonvalot, S. / Haas, R. / Haller, F. / Hohenberger, P. / Moreau, G. / van der Graaf, W.T.A. et al. | 2015
- 137
-
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumoursSpicer, J. / Baird, R. / Suder, A. / Cresti, N. / Corbacho, J.G. / Hogarth, L. / Frenkel, E. / Matsumoto, S. / Kawabata, I. et al. | 2015
- 146
-
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumoursWeihrauch, M.R. / Richly, H. / von Bergwelt-Baildon, M.S. / Becker, H.J. / Schmidt, M. / Hacker, U.T. / Shimabukuro-Vornhagen, A. / Holtick, U. / Nokay, B. et al. | 2015
- 157
-
Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinomaHokuto, D. / Sho, M. / Yamato, I. / Yasuda, S. / Obara, S. / Nomi, T. / Nakajima, Y. et al. | 2015
- 166
-
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trialsFaron, M. / Pignon, J.P. / Malka, D. / Bourredjem, A. / Douillard, J.Y. / Adenis, A. / Elias, D. / Bouche, O. / Ducreux, M. et al. | 2015
- 177
-
Recurrence and cancer-specific survival according to the expression of IL-4R@a and IL-13R@a1 in patients with oral cavity cancerKwon, M. / Kim, J.W. / Roh, J.L. / Park, Y. / Cho, K.J. / Choi, S.H. / Nam, S.Y. / Kim, S.Y. / Lee, B.H. et al. | 2015
- 186
-
Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patientsColombo, C. / Miceli, R. / Le Pechoux, C. / Palassini, E. / Honore, C. / Stacchiotti, S. / Mir, O. / Casali, P.G. / Domont, J. et al. | 2015
- 193
-
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?Ben Arush, M. / Minard-Colin, V. / Mosseri, V. / Defachelles, A.S. / Bergeron, C. / Algret, N. / Fasola, S. / Andre, N. / Thebaud, E. et al. | 2015
- 202
-
Comparison of Response Evaluation Criteria in Solid Tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: A retrospective analysisFrench Sarcoma Group / Taieb, S. / Saada-Bouzid, E. / Tresch, E. / Ryckewaert, T. / Bompas, E. / Italiano, A. / Guillemet, C. / Peugniez, C. et al. | 2015
- 210
-
Tenosynovial giant cell tumourpigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitorsPalmerini, E. / Staals, E.L. / Maki, R.G. / Pengo, S. / Cioffi, A. / Gambarotti, M. / Picci, P. / Daolio, P.A. / Parafioriti, A. et al. | 2015
- 218
-
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancerVassal, G. / Rousseau, R. / Blanc, P. / Moreno, L. / Bode, G. / Schwoch, S. / Schrappe, M. / Skolnik, J. / Bergman, L. et al. | 2015
- 225
-
Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - The United Kingdom experienceRenal Tumours Committee of the Children's Cancer and Leukaemia Group (CCLG) / Irtan, S. / Jitlal, M. / Bate, J. / Powis, M. / Vujanic, G. / Kelsey, A. / Walker, J. / Mitchell, C. et al. | 2015
- 233
-
Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centreKhoja, L. / McGurk, A. / O'Hara, C. / Chow, S. / Hasan, J. et al. | 2015
- 241
-
Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registriesAnttila, A. / Lonnberg, S. / Ponti, A. / Suonio, E. / Villain, P. / Coebergh, J.W. / von Karsa, L. et al. | 2015
- 252
-
ANKHD1 represses p21 (WAF1CIP1) promoter and promotes multiple myeloma cell growthDhyani, A. / Machado-Neto, J.A. / Favaro, P. / Saad, S.T.O. et al. | 2015
- 260
-
Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancersKang, L. / Sun, J. / Wen, X. / Cui, J. / Wang, G. / Hoffman, A.R. / Hu, J.F. / Li, W. et al. | 2015
- 271
-
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers InitiativeBogaerts, J. / Sydes, M.R. / Keat, N. / McConnell, A. / Benson, A. / Ho, A. / Roth, A. / Fortpied, C. / Eng, C. et al. | 2015
- 282
-
Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohortVos, E.L. / Jager, A. / Verhoef, C. / Voogd, A.C. / Koppert, L.B. et al. | 2015
- 292
-
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivorsEckhoff, L. / Knoop, AS. / Jensen, MB. / Ewertz, M. et al. | 2015
- 301
-
Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994BIG 1-00 phase III trialFei, F. / Messina, C. / Slaets, L. / Chakiba, C. / Cameron, D. / Bogaerts, J. / Bonnefoi, H. et al. | 2015
- 310
-
Survival of older patients with metastasised breast cancer lags behind despite evolving treatment strategies - A population-based studyde Glas, N.A. / Bastiaannet, E. / de Craen, A.J.M. / van de Velde, C.J.H. / Siesling, S. / Liefers, G.J. / Portielje, J.E.A. et al. | 2015
- 317
-
Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancerLUME-Lung 1 Study Group / Novello, S. / Kaiser, R. / Mellemgaard, A. / Douillard, J.Y. / Orlov, S. / Krzakowski, M. / von Pawel, J. / Gottfried, M. et al. | 2015
- 327
-
Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizonsHollebecque, A. / Malka, D. / Ferte, C. / Ducreux, M. / Boige, V. et al. | 2015
- 340
-
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumourSatoh, T. / Aoki, Y. / Kasamatsu, T. / Ochiai, K. / Takano, M. / Watanabe, Y. / Kikkawa, F. / Takeshima, N. / Hatae, M. et al. | 2015
- 352
-
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trialMahner, S. / Meier, W. / du Bois, A. / Brown, C. / Lorusso, D. / Dell'Anna, T. / Cretin, J. / Havsteen, H. / Bessette, P. et al. | 2015
- 359
-
PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxelCoupe, N. / Corrie, P. / Hategan, M. / Larkin, J. / Gore, M. / Gupta, A. / Wise, A. / Suter, S. / Ciria, C. et al. | 2015
- 367
-
Treatment modifications in tumour necrosis factor-@a (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomasDeroose, J.P. / Grunhagen, D.J. / de Wilt, J.H.W. / Eggermont, A.M.M. / Verhoef, C. et al. | 2015
- 374
-
Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyFrezza, A.M. / Cesari, M. / Baumhoer, D. / Biau, D. / Bielack, S. / Campanacci, D.A. / Casanova, J. / Esler, C. / Ferrari, S. et al. | 2015
- 382
-
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patientsRoth, P. / Keller, A. / Hoheisel, J.D. / Codo, P. / Bauer, A.S. / Backes, C. / Leidinger, P. / Meese, E. / Thiel, E. et al. | 2015
- 391
-
Blinded double reading yields a higher programme sensitivity than non-blinded double reading at digital screening mammography: A prospected population based study in the south of The NetherlandsKlompenhouwer, E.G. / Voogd, A.C. / den Heeten, G.J. / Strobbe, L.J.A. / de Haan, A.F.J. / Wauters, C.A. / Broeders, M.J.M. / Duijm, L.E.M. et al. | 2015
- 400
-
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancerFakkert, I.E. / Abma, E.M. / Westrik, I.G. / Lefrandt, J.D. / Wolffenbuttel, B.H.R. / Oosterwijk, J.C. / Slart, R.H.J.A. / van der Veer, E. / de Bock, G.H. et al. | 2015
- 409
-
MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomasGattolliat, C.H. / Uguen, A. / Pesson, M. / Trillet, K. / Simon, B. / Doucet, L. / Robaszkiewicz, M. / Corcos, L. et al. | 2015
- 421
-
PD-L1 expression in small cell neuroendocrine carcinomasSchultheis, A.M. / Scheel, A.H. / Ozretic, L. / George, J. / Thomas, R.K. / Hagemann, T. / Zander, T. / Wolf, J. / Buettner, R. et al. | 2015
- 427
-
Evaluating iatrogenic prescribing: Development of an oncology-focused trigger toolHebert, G. / Netzer, F. / Ferrua, M. / Ducreux, M. / Lemare, F. / Minvielle, E. et al. | 2015
- 437
-
Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancerChan, R.J. / McCarthy, A.L. / Devenish, J. / Sullivan, K.A. / Chan, A. et al. | 2015
- 451
-
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trialLivi, L. / Meattini, I. / Marrazzo, L. / Simontacchi, G. / Pallotta, S. / Saieva, C. / Paiar, F. / Scotti, V. / De Luca Cardillo, C. et al. | 2015
- 464
-
Molecular mechanisms of constitutive and inducible NF-kappaB activation in oesophageal adenocarcinomaAbdel-Latif, M.M.M. / Kelleher, D. / Reynolds, J.V. et al. | 2015
- 473
-
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyDi Bartolomeo, M. / Ciarlo, A. / Bertolini, A. / Barni, S. / Verusio, C. / Aitini, E. / Pietrantonio, F. / Iacovelli, R. / Dotti, K.F. et al. | 2015
- 482
-
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancerRyu, M.H. / Yoo, C. / Kim, J.G. / Ryoo, B.Y. / Park, Y.S. / Park, S.R. / Han, H.S. / Chung, I.J. / Song, E.K. et al. | 2015
- 489
-
Overall survival and renal function after partial and radical nephrectomy among older patients with localised renal cell carcinoma: A propensity-matched multicentre studyChung, J.S. / Son, N.H. / Lee, S.E. / Hong, S.K. / Lee, S.C. / Kwak, C. / Hong, S.H. / Kim, Y.J. / Kang, S.H. et al. | 2015
- 498
-
Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)van den Heuvel-Eibrink, M.M. / van Tinteren, H. / Bergeron, C. / Coulomb-L'Hermine, A. / de Camargo, B. / Leuschner, I. / Sandstedt, B. / Acha, T. / Godzinski, J. et al. | 2015
- 507
-
Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiencyPoprach, A. / Bortlicek, Z. / Melichar, B. / Lakomy, R. / Svoboda, M. / Kiss, I. / Zemanova, M. / Fiala, O. / Kubackova, K. et al. | 2015
- 514
-
Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalenceTinhofer, I. / Johrens, K. / Keilholz, U. / Kaufmann, A. / Lehmann, A. / Weichert, W. / Stenzinger, A. / Stromberger, C. / Klinghammer, K. et al. | 2015
- 522
-
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastomaWestphal, M. / Heese, O. / Steinbach, J.P. / Schnell, O. / Schackert, G. / Mehdorn, M. / Schulz, D. / Simon, M. / Schlegel, U. et al. | 2015
- 533
-
Glioblastoma in England: 2007-2011Brodbelt, A. / Greenberg, D. / Winters, T. / Williams, M. / Vernon, S. / Collins, V.P. et al. | 2015
- 543
-
Ovarian Sertoli Leydig cell tumours in children and adolescents: An analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT)Schneider, D.T. / Orbach, D. / Cecchetto, G. / Stachowicz-Stencel, T. / Brummel, B. / Brecht, I.B. / Bisogno, G. / Ferrari, A. / Reguerre, Y. et al. | 2015
- 551
-
Internet-based technologies to improve cancer care coordination: Current use and attitudes among cancer patientsGirault, A. / Ferrua, M. / Lalloue, B. / Sicotte, C. / Fourcade, A. / Yatim, F. / Hebert, G. / Di Palma, M. / Minvielle, E. et al. | 2015
- 558
-
Cancer incidence in participants in a long-distance ski race (Vasaloppet, Sweden) compared to the background populationHallmarker, U. / James, S. / Michaelsson, K. / Arnlov, J. / Sandin, F. / Holmberg, L. et al. | 2015
- 569
-
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische OnkologieLorenzen, S. / Riera Knorrenschild, J. / Haag, G.M. / Pohl, M. / Thuss-Patience, P. / Bassermann, F. / Helbig, U. / Weiszinger, F. / Schnoy, E. et al. | 2015
- 577
-
Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - A critical appraisalRocken, C. / Behrens, H.M. et al. | 2015
- 587
-
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysisPietrantonio, F. / Petrelli, F. / Coinu, A. / Di Bartolomeo, M. / Borgonovo, K. / Maggi, C. / Cabiddu, M. / Iacovelli, R. / Bossi, I. et al. | 2015
- 595
-
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: A Southern China Urology Cancer Consortium TrialXie, M. / He, C.s. / Huang, J.K. / Lin, Q.z. et al. | 2015
- 604
-
Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomyOhwaki, K. / Endo, F. / Hattori, K. et al. | 2015
- 610
-
The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapyThurner, E.M. / Krenn-Pilko, S. / Langsenlehner, U. / Stojakovic, T. / Pichler, M. / Gerger, A. / Kapp, K.S. / Langsenlehner, T. et al. | 2015
- 620
-
Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence riskVasconcelos, I. / de Sousa Mendes, M. et al. | 2015
- 632
-
Validation of methylation markers for diagnosis of oral cavity cancerArantes, L.M.R.B. / de Carvalho, A.C. / Melendez, M.E. / Centrone, C.C. / Gois-Filho, J.F. / Toporcov, T.N. / Caly, D.N. / Tajara, E.H. et al. | 2015
- 642
-
Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progressionScholtens, A. / Geukes Foppen, M.H. / Blank, C.U. / van Thienen, J.V. / van Tinteren, H. / Haanen, J.B. et al. | 2015
- 653
-
Prospective evaluation of follow-up in melanoma patients in Germany - Results of a multicentre and longitudinal studyLivingstone, E. / Krajewski, C. / Eigentler, T.K. / Windemuth-Kieselbach, C. / Benson, S. / Elsenbruch, S. / Hauschild, A. / Rompel, R. / Meiss, F. et al. | 2015
- 668
-
Stereotactic body radiation therapy for lung metastases from soft tissue sarcomaNavarria, P. / Ascolese, A.M. / Cozzi, L. / Tomatis, S. / D'Agostino, G.R. / De Rose, F. / De Sanctis, R. / Marrari, A. / Santoro, A. et al. | 2015
- 675
-
Increased risk of antidepressant use in childhood cancer survivors: A Danish population-based cohort studyLund, L.W. / Winther, J.F. / Cederkvist, L. / Andersen, K.K. / Dalton, S.O. / Appel, C.W. / Rechnitzer, C. / Schmiegelow, K. / Johansen, C. et al. | 2015
- 685
-
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer| 2015
- 697
-
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude| 2015
- 705
-
Obesity in breast cancer - What is the risk factor?| 2015
- 721
-
Influence of censoring on conclusions of trials for women with metastatic breast cancer| 2015
- 725
-
The risk of prostate cancer for men on aspirin, statin or antidiabetic medications| 2015
- 734
-
A new method of surgical margin assuring for abdominal radical trachelectomy in frozen section| 2015
- 742
-
Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group| 2015
- 751
-
Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis| 2015
- 758
-
Are we ready to predict late effects? A systematic review of clinically useful prediction models| 2015
- 767
-
Relative mortality rates from incident chronic diseases among breast cancer survivors - A 14year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007| 2015
- 776
-
High-sensitivity HPV genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis| 2015
- 786
-
Plasma 25-hydroxyvitamin D levels and survival of colorectal cancer patients: A meta-analysis| 2015
- 791
-
Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profilesVignot, S. / Lefebvre, C. / Frampton, G.M. / Meurice, G. / Yelensky, R. / Palmer, G. / Capron, F. / Lazar, V. / Hannoun, L. et al. | 2015
- 800
-
Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: A systematic review and pooled-analysisPetrelli, F. / Pietrantonio, F. / Cremolini, C. / Di Bartolomeo, M. / Coinu, A. / Lonati, V. / de Braud, F. / Barni, S. et al. | 2015
- 808
-
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trialNishikawa, K. / Fujitani, K. / Inagaki, H. / Akamaru, Y. / Tokunaga, S. / Takagi, M. / Tamura, S. / Sugimoto, N. / Shigematsu, T. et al. | 2015
- 817
-
Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up studyGarcia-Albeniz, X. / Chan, J.M. / Paciorek, A. / Logan, R.W. / Kenfield, S.A. / Cooperberg, M.R. / Carroll, P.R. / Hernan, M. et al. | 2015
- 825
-
Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: A metaanalysis of four prospective randomised phase III trials with 5114 patientsSehouli, J. / Fotopoulou, C. / Erol, E. / Richter, R. / Reuss, A. / Mahner, S. / Lauraine, E.P. / Kristensen, G. / Herrstedt, J. et al. | 2015
- 833
-
Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanomaSchadendorf, D. / Amonkar, M.M. / Stroyakovskiy, D. / Levchenko, E. / Gogas, H. / de Braud, F. / Grob, J.J. / Bondarenko, I. / Garbe, C. et al. | 2015
- 841
-
RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 statusSonnemann, J. / Grauel, D. / Blumel, L. / Hentschel, J. / Marx, C. / Blumrich, A. / Focke, K. / Becker, S. / Wittig, S. et al. | 2015
- 852
-
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibLee, C.K. / Goldstein, D. / Gibbs, E. / Joensuu, H. / Zalcberg, J. / Verweij, J. / Casali, P.G. / Maki, R.G. / Cioffi, A. et al. | 2015
- 861
-
443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011Brecht, I.B. / Garbe, C. / Gefeller, O. / Pfahlberg, A. / Bauer, J. / Eigentler, T.K. / Offenmueller, S. / Schneider, D.T. / Leiter, U. et al. | 2015
- 869
-
The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populationsAutier, P. / Koechlin, A. / Boniol, M. et al. | 2015
- 879
-
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesWinterhoff, B. / Freyer, L. / Hammond, E. / Giri, S. / Mondal, S. / Roy, D. / Teoman, A. / Mullany, S.A. / Hoffmann, R. et al. | 2015
- 893
-
Mutation specific functions of EGFR result in a mutation-specific downstream pathway activationErdem-Eraslan, L. / Gao, Y. / Kloosterhof, N.K. / Atlasi, Y. / Demmers, J. / Sacchetti, A. / Kros, J.M. / Sillevis Smitt, P. / Aerts, J. et al. | 2015
- 907
-
Do participants in adjuvant breast cancer trials reflect the breast cancer patient population?Treweek, S. / Dryden, R. / McCowan, C. / Harrow, A. / Thompson, A.M. et al. | 2015
- 915
-
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatmentvan der Heiden-van der Loo, M. / de Munck, L. / Sonke, G.S. / van Dalen, T. / van Diest, P.J. / van den Bongard, H.J.G.D. / Peeters, P.H.M. / Rutgers, E.J.T. et al. | 2015
- 922
-
Microsatellite instability, disease-free survival and role of tumour infiltrating lymphocytes (Invited editorial on 'Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicenter study')Lynch, H.T. / Lanspa, S.J. / Snyder, C.L. / Drescher, K.M. et al. | 2015
- 925
-
Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre studyTougeron, D. / Sickersen, G. / Mouillet, G. / Zaanan, A. / Trouilloud, I. / Coriat, R. / Aparicio, T. / Des Guetz, G. et al. | 2015
- 935
-
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)Yoshida, M. / Muro, K. / Tsuji, A. / Hamamoto, Y. / Yoshino, T. / Yoshida, K. / Shirao, K. / Miyata, Y. / Takahari, D. et al. | 2015
- 942
-
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialArgiles, G. / Saunders, M.P. / Rivera, F. / Sobrero, A. / Benson, A. / Guillen Ponce, C. / Cascinu, S. / Van Cutsem, E. / Macpherson, I.R. et al. | 2015
- 950
-
Cervical cancer screening in Europe: Quality assurance and organisation of programmesElfstrom, K.M. / Arnheim-Dahlstrom, L. / von Karsa, L. / Dillner, J. et al. | 2015
- 969
-
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activationHuang, D.S. / Wang, Z. / He, X.J. / Diplas, B.H. / Yang, R. / Killela, P.J. / Meng, Q. / Ye, Z.Y. / Wang, W. et al. | 2015
- 977
-
Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndromeDurno, C.A. / Sherman, P.M. / Aronson, M. / Malkin, D. / Hawkins, C. / Bakry, D. / Bouffet, E. / Gallinger, S. et al. | 2015
- 984
-
The power of phase II end-points for different possible mechanisms of action of an experimental treatmentWason, J.M.S. / Dentamaro, A. / Eisen, T.G. et al. | 2015
- 995
-
Response to letter commenting on ''Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)''van den Heuvel-Eibrink, M.M. / Pritchard-Jones, K. / van Tinteren, H. / Graf, N. et al. | 2015
- 997
-
EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluationCoebergh, J.W. / van den Hurk, C. / Rosso, S. / Comber, H. / Storm, H. / Zanetti, R. / Sacchetto, L. / Janssen-Heijnen, M. / Thong, M. et al. | 2015
- 1018
-
A basis for translational cancer research on aetiology, pathogenesis and prognosis: Guideline for standardised and population-based linkages of biobanks to cancer registriesDillner, J. et al. | 2015
- 1028
-
Cancer registration, public health and the reform of the European data protection framework: Abandoning or improving European public health research?on behalf of the Eurocourse Work Package 2 Group / Andersen, M.R. / Storm, H.H. et al. | 2015
- 1039
-
Uses of cancer registries for public health and clinical research in Europe: Results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010-2012Siesling, S. / Louwman, W.J. / Kwast, A. / van den Hurk, C. / O'Callaghan, M. / Rosso, S. / Zanetti, R. / Storm, H. / Comber, H. et al. | 2015
- 1050
-
EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees(R) in Europe: From roots to fruitsCoebergh, J.W. / van den Hurk, C. / Louwman, M. / Comber, H. / Rosso, S. / Zanetti, R. / Sacchetto, L. / Storm, H. / van Veen, E.B. et al. | 2015
- 1064
-
Registration of childhood cancer: Moving towards pan-European coverage?Steliarova-Foucher, E. / Stiller, C. / Colombet, M. / Kaatsch, P. / Zanetti, R. / Peris-Bonet, R. et al. | 2015
- 1080
-
Reprint of: Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registriesAnttila, A. / Lonnberg, S. / Ponti, A. / Suonio, E. / Villain, P. / Coebergh, J.W. / von Karsa, L. et al. | 2015
- 1082
-
Power analysis to detect time trends on population-based cancer registries data: When size really mattersZanetti, R. / Sera, F. / Sacchetto, L. / Coebergh, J.W. / Rosso, S. et al. | 2015
- 1091
-
Completeness and timeliness: Cancer registries couldshould improve their performanceZanetti, R. / Schmidtmann, I. / Sacchetto, L. / Binder-Foucard, F. / Bordoni, A. / Coza, D. / Ferretti, S. / Galceran, J. / Gavin, A. et al. | 2015
- 1099
-
Completeness and registration bias in PROCARE, a Belgian multidisciplinary project on cancer of the rectum with participation on a voluntary basisPROCARE / Jegou, D. / Penninckx, F. / Vandendael, T. / Bertrand, C. / Van Eycken, E. et al. | 2015
- 1109
-
Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnosesGavin, A. / Rous, B. / Marcos-Gragera, R. / Middleton, R. / Steliarova-Foucher, E. / Maynadie, M. / Zanetti, R. / Visser, O. et al. | 2015
- 1123
-
Choosing the net survival method for cancer survival estimationSeppa, K. / Hakulinen, T. / Pokhrel, A. et al. | 2015
- 1130
-
Reprint of: Evaluation of data quality in the National Prostate Cancer Register of SwedenTomic, K. / Sandin, F. / Wigertz, A. / Robinson, D. / Lambe, M. / Stattin, P. et al. | 2015
- 1131
-
The European Cancer Observatory: A new data resourceSteliarova-Foucher, E. / O'Callaghan, M. / Ferlay, J. / Masuyer, E. / Rosso, S. / Forman, D. / Bray, F. / Comber, H. et al. | 2015
- 1144
-
Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010Lortet-Tieulent, J. / Renteria, E. / Sharp, L. / Weiderpass, E. / Comber, H. / Baas, P. / Bray, F. / Coebergh, J.W. / Soerjomataram, I. et al. | 2015
- 1164
-
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer ObservatoryArnold, M. / Karim-Kos, H.E. / Coebergh, J.W. / Byrnes, G. / Antilla, A. / Ferlay, J. / Renehan, A.G. / Forman, D. / Soerjomataram, I. et al. | 2015
- 1188
-
Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt projectStorm, H.H. / Engholm, G. / Pritzkuleit, R. / Kejs, A.M.T. / Katalinic, A. / Dunst, J. / Hollander, N.H. et al. | 2015
- 1199
-
Reprint of: Cancer incidence and mortality patterns in South Eastern Europe in the last decade: Gaps persist compared with the rest of EuropeZnaor, A. / van den Hurk, C. / Primic-Zakelj, M. / Agius, D. / Coza, D. / Demetriou, A. / Dimitrova, N. / Eser, S. / Karakilinc, H. et al. | 2015
- 1201
-
Reprint of: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012Ferlay, J. / Steliarova-Foucher, E. / Lortet-Tieulent, J. / Rosso, S. / Coebergh, J.W.W. / Comber, H. / Forman, D. / Bray, F. et al. | 2015
- 1203
-
Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term carePanCare Network / Hjorth, L. / Haupt, R. / Skinner, R. / Grabow, D. / Byrne, J. / Karner, S. / Levitt, G. / Michel, G. et al. | 2015
- 1212
-
Fulvestrant with or without selumetinib, a MEK 12 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 2108Zaman, K. / Winterhalder, R. / Mamot, C. / Hasler-Strub, U. / Rochlitz, C. / Mueller, A. / Berset, C. / Wiliders, H. / Perey, L. et al. | 2015
- 1221
-
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: A European Society of Breast Cancer Specialists database analysiseusomaDB Working Group / Kiderlen, M. / Ponti, A. / Tomatis, M. / Boelens, P.G. / Bastiaannet, E. / Wilson, R. / van de Velde, C.J.H. / Audisio, R.A. et al. | 2015
- 1231
-
Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancerDouillard, J.Y. / Siena, S. / Peeters, M. / Koukakis, R. / Terwey, J.H. / Tabernero, J. et al. | 2015
- 1243
-
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerBokemeyer, C. / Kohne, C.H. / Ciardiello, F. / Lenz, H.J. / Heinemann, V. / Klinkhardt, U. / Beier, F. / Duecker, K. / van Krieken, J.H. et al. | 2015
- 1253
-
Streptozocin5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumoursDilz, L.M. / Denecke, T. / Steffen, I.G. / Prasad, V. / von Weikersthal, L.F. / Pape, U.F. / Wiedenmann, B. / Pavel, M. et al. | 2015
- 1263
-
Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: Results from the population-based PROFILES registryVerhaar, S. / Vissers, P.A.J. / Maas, H. / van de Poll-Franse, L.V. / van Erning, F.N. / Mols, F. et al. | 2015
- 1274
-
Combination antiemetic therapy with aprepitantfosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trialMulti-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO) / Nishimura, J. / Satoh, T. / Fukunaga, M. / Takemoto, H. / Nakata, K. / Ide, Y. / Fukuzaki, T. / Kudo, T. et al. | 2015
- 1283
-
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 studyon behalf of the Scandinavian Prostate Cancer Group / Thomsen, F.B. / Brasso, K. / Christensen, I.J. / Johansson, J.E. / Angelsen, A. / Tammela, T.L.J. / Iversen, P. et al. | 2015
- 1293
-
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patientsPowles, T. / Bracarda, S. / Chen, M. / Norry, E. / Compton, N. / Heise, M. / Hutson, T. / Harter, P. / Carpenter, C. et al. | 2015
- 1303
-
Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patientsCho, J.K. / Lee, G.J. / Yi, K.I. / Cho, K.S. / Choi, N. / Kim, J.S. / Kim, H. / Oh, D. / Choi, S.K. et al. | 2015
- 1312
-
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trialBui-Nguyen, B. / Butrynski, J.E. / Penel, N. / Blay, J.Y. / Isambert, N. / Milhem, M. / Kerst, J.M. / Reyners, A. et al. | 2015
- 1321
-
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trialDirven, L. / van den Bent, M.J. / Bottomley, A. / van der Meer, N. / van der Holt, B. / Vos, M.J. / Walenkamp, A.M.E. / Beerepoot, L.V. et al. | 2015
- 1331
-
Old age as risk indicator for poor end-of-life care quality - A population-based study of cancer deaths from the Swedish Register of Palliative CareLindskog, M. / Tavelin, B. / Lundstrom, S. et al. | 2015
- 1340
-
Childhood height increases the risk of prostate cancer mortalityAarestrup, J. / Gamborg, M. / Cook, M.B. / Baker, J.L. et al. | 2015
- 1346
-
Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: Analyses based on 4,407,971 screening colonoscopiesBrenner, H. / Altenhofen, L. / Stock, C. / Hoffmeister, M. et al. | 2015
- 1355
-
Do we need randomised trials for rare cancers?Prasad, V. / Oseran, A. et al. | 2015
- 1358
-
Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trialMartelli, G. / Boracchi, P. / Guzzetti, E. / Marano, G. / Lozza, L. / Agresti, R. / Ferraris, C. / Piromalli, D. / Greco, M. et al. | 2015
- 1365
-
Cardiorespiratory fitness, C-reactive protein and lung cancer risk: A prospective population-based cohort studyPletnikoff, P.P. / Laukkanen, J.A. / Tuomainen, T.P. / Kauhanen, J. / Rauramaa, R. / Ronkainen, K. / Kurl, S. et al. | 2015
- 1371
-
First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive TumoursSpanish Cooperative Group for the Treatment of Digestive Tumours (TTD) / Sastre, J. / Massuti, B. / Pulido, G. / Guillen-Ponce, C. / Benavides, M. / Manzano, J.L. / Reboredo, M. / Rivera, F. et al. | 2015
- 1381
-
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancerGrunnet, M. / Christensen, I.J. / Lassen, U. / Jensen, L.H. / Lydolph, M. / Knox, J.J. / McNamara, M.G. / Jitlal, M. / Wasan, H. et al. | 2015
- 1389
-
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysisFrampton, A.E. / Krell, J. / Jamieson, N.B. / Gall, T.M.H. / Giovannetti, E. / Funel, N. / Mato Prado, M. / Krell, D. / Habib, N.A. et al. | 2015
- 1405
-
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17Brule, S.Y. / Jonker, D.J. / Karapetis, C.S. / O'Callaghan, C.J. / Moore, M.J. / Wong, R. / Tebbutt, N.C. / Underhill, Cr. / Yip, D. et al. | 2015
- 1415
-
A functional variant at miRNA-122 binding site in IL-1@a 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancerZhang, Y. / Sturgis, E.M. / Sun, Y. / Sun, C. / Wei, Q. / Huang, Z. / Li, G. et al. | 2015
- 1424
-
Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatmentSchoot, R.A. / Slater, O. / Ronckers, C.M. / Zwinderman, A.H. / Balm, A.J.M. / Hartley, B. / van den Brekel, M.W. / Gupta, S. / Saeed, P. et al. | 2015
- 1435
-
Long-term outcome in BRAF^V^6^0^0^E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progressionPuzanov, I. / Amaravadi, R.K. / McArthur, G.A. / Flaherty, K.T. / Chapman, P.B. / Sosman, J.A. / Ribas, A. / Shackleton, M. / Hwu, P. et al. | 2015
- 1444
-
Childhood central nervous system tumours: Incidence and time trends in 13 Southern and Eastern European cancer registriesPapathoma, P. / Thomopoulos, T.P. / Karalexi, M.A. / Ryzhov, A. / Zborovskaya, A. / Dimitrova, N. / Zivkovic, S. / Eser, S. / Antunes, L. et al. | 2015
- 1456
-
A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30yearsRebolj, M. / Bonde, J. / Ejegod, D. / Preisler, S. / Rygaard, C. / Lynge, E. et al. | 2015
- 1467
-
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone diseaseDiel, I.J. / Body, J.J. / Stopeck, A.T. / Vadhan-Raj, S. / Spencer, A. / Steger, G. / von Moos, R. / Goldwasser, F. / Feng, A. et al. | 2015
- 1476
-
In regard to Livi et al. ''Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5year survival analysis of a phase 3 randomised controlled trial''Bhattacharjee, A. / Chakraborty, S. et al. | 2015
- 1478
-
Authors replyMeattini, I. / Saieva, C. / Livi, L. et al. | 2015
- 1481
-
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancerSonnenblick, A. / Francis, P.A. / Azim, H.A. / de Azambuja, E. / Nordenskjold, B. / Gutierez, J. / Quinaux, E. / Mastropasqua, M.G. / Ameye, L. et al. | 2015
- 1490
-
Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcomeGoldrat, O. / Kroman, N. / Peccatori, F.A. / Cordoba, O. / Pistilli, B. / Lidegaard, O. / Demeestere, I. / Azim, H.A. et al. | 2015
- 1497
-
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD studyElshof, L.E. / Tryfonidis, K. / Slaets, L. / van Leeuwen-Stok, A.E. / Skinner, V.P. / Dif, N. / Pijnappel, R.M. / Bijker, N. / Rutgers, E.J.Th. et al. | 2015
- 1511
-
Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)EORTC-LCG / O'Brien, M.E.R. / Gaafar, R. / Hasan, B. / Menis, J. / Cufer, T. / Popat, S. / Woll, P.J. / Surmont, V. et al. | 2015
- 1529
-
Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?Australasian Lung Cancer Trials Group (ALTG) / Blinman, P. / Hughes, B. / Crombie, C. / Christmas, T. / Hudson, M. / Veillard, A.S. / Muljadi, N. / Millward, M. et al. | 2015
- 1538
-
Long-term quality of life after oesophagectomy with gastric conduit interposition for cancerAkkerman, R.D.L. / Haverkamp, L. / van Rossum, P.S.N. / van Hillegersberg, R. / Ruurda, J.P. et al. | 2015
- 1546
-
Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trialSinn, M. / Riess, H. / Sinn, B.V. / Stieler, J.M. / Pelzer, U. / Striefler, J.K. / Oettle, H. / Bahra, M. / Denkert, C. et al. | 2015
- 1555
-
A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancerChu, F.M. / Sartor, O. / Gomella, L. / Rudo, T. / Somerville, M.C. / Hereghty, B. / Manyak, M.J. et al. | 2015
- 1570
-
Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysisYan, M. / Kumachev, A. / Siu, L.L. / Chan, K.K.W. et al. | 2015
- 1580
-
A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancerTertipis, N. / Hammar, U. / Nasman, A. / Vlastos, A. / Nordfors, C. / Grun, N. / Ahrlund-Richter, A. / Sivars, L. / Haeggblom, L. et al. | 2015
- 1588
-
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerLim, S.M. / Chung, W.Y. / Nam, K.H. / Kang, S.W. / Lim, J.Y. / Kim, H.G. / Shin, S.H. / Sun, J.M. / Kim, S.G. et al. | 2015
- 1596
-
Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patientsJohn, K. / Rosner, I. / Keilholz, U. / Gauler, T. / Bantel, H. / Grunwald, V. et al. | 2015
- 1603
-
MED12 and uterine smooth muscle oncogenesis: State of the art and perspectivesCroce, S. / Chibon, F. et al. | 2015
- 1611
-
Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgeryJoensuu, H. / Martin-Broto, J. / Nishida, T. / Reichardt, P. / Schoffski, P. / Maki, R.G. et al. | 2015
- 1618
-
Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor modelBaba, M. / Maeda, I. / Morita, T. / Inoue, S. / Ikenaga, M. / Matsumoto, Y. / Sekine, R. / Yamaguchi, T. / Hirohashi, T. et al. | 2015
- 1630
-
Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programmeGondos, A. / Krilaviciute, A. / Smailyte, G. / Ulys, A. / Brenner, H. et al. | 2015
- 1638
-
Interplay between microRNAs and WNT@b-catenin signalling pathway regulates epithelial-mesenchymal transition in cancerGhahhari, N.M. / Babashah, S. et al. | 2015
- 1650
-
Note of clarification of data on the association between CYP2E1 RsaI polymorphism and lung cancer riskZhai, W. / Feng, R. / Yang, H. / Wang, Y. et al. | 2015
- 1657
-
Duration of Trastuzumab. In matters of the heart, one size may not fit all?Simmons, Christine / Dent, Susan / Brezden-Masley, Christine et al. | 2015
- 1660
-
Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III studyPivot, X. / Suter, T. / Nabholtz, J.M. / Pierga, J.Y. / Espie, M. / Lortholary, A. / Khayat, D. / Pauporte, I. / Romieu, G. et al. | 2015
- 1667
-
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerTerenziani, M. / Massimino, M. / Magazzu, D. / Gandola, L. / Capri, G. / Carcangiu, M.L. / Catania, S. / Di Russo, A. / Gennaro, M. et al. | 2015
- 1675
-
Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage diseaseOrsini, R.G. / Verhoeven, R.H.A. / Lemmens, V.E.P.P. / van Steenbergen, L.N. / de Hingh, I.H.J.T. / Nieuwenhuijzen, G.A.P. / Rutten, H.J.T. et al. | 2015
- 1683
-
Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation aloneVincent, J. / Mariette, C. / Pezet, D. / Huet, E. / Bonnetain, F. / Bouche, O. / Conroy, T. / Roullet, B. / Seitz, J.F. et al. | 2015
- 1694
-
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal diseaseLamarca, Angela / Benafif, Sarah / Ross, Paul / Bridgewater, John / Valle, Juan W. et al. | 2015
- 1704
-
Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trialsPeeters, M. / Kafatos, G. / Taylor, A. / Gastanaga, V.M. / Oliner, K.S. / Hechmati, G. / Terwey, J.H. / van Krieken, J.H. et al. | 2015
- 1714
-
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancerHussain, Maha / Rathkopf, Dana / Liu, Glenn / Armstrong, Andrew / Kelly, Wm. Kevin / Ferrari, Anna / Hainsworth, John / Joshi, Adarsh / Hozak, Rebecca R. / Yang, Ling et al. | 2015
- 1725
-
Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseasesBolze, Pierre-Adrien / Attia, Jocelyne / Massardier, Jérôme / Seckl, Michael J. / Massuger, Leon / van Trommel, Nienke / Niemann, Isa / Hajri, Touria / Schott, Anne-Marie / Golfier, François et al. | 2015
- 1732
-
Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesionsSerrano, B. / de Sanjose, S. / Tous, S. / Quiros, B. / Munoz, N. / Bosch, X. / Alemany, L. et al. | 2015
- 1742
-
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer - A pooled analysis of PORTEC 1 and 2 trialsBosse, T. / Peters, E.E.M. / Creutzberg, C.L. / Jurgenliemk-Schulz, I.M. / Jobsen, J.J. / Mens, J.W.M. / Lutgens, L.C.H.W. / van der Steen-Banasik, E.M. / Smit, V.T.H.B.M. et al. | 2015
- 1751
-
Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: A systematic reviewLi, X. / Li, J. / Wu, X. et al. | 2015
- 1760
-
Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic areaHuang, Pei-Yu / Zeng, Qi / Cao, Ka-Jia / Guo, Xiang / Guo, Ling / Mo, Hao-Yuan / Wu, Pei-Hong / Qian, Chao-Nan / Mai, Hai-Qiang / Hong, Ming-Huang et al. | 2015
- 1771
-
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification systemYou, Rui / Zou, Xiong / Wang, Shun-Lan / Jiang, Rou / Tang, Lin-Quan / Zhang, Wei-Dong / Li, Li / Zhang, Meng-Xia / Shen, Guo-Ping / Guo, Ling et al. | 2015
- 1780
-
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanomaTejera-Vaquerizo, Antonio / Nagore, Eduardo / Puig, Susana / Robert, Caroline / Saiag, Philippe / Martín-Cuevas, Paula / Gallego, Elena / Herrera-Acosta, Enrique / Aguilera, José / Malvehy, Josep et al. | 2015
- 1794
-
A randomised, open-label, phase II study of neoadjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaDavis, E.J. / Chugh, R. / Zhao, L. / Lucas, D.R. / Biermann, J.S. / Zalupski, M.M. / Feng, M. / Wong, S.L. / Jacobson, J. et al. | 2015
- 1803
-
Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinomaPreusser, M. / Berghoff, A.S. / Koller, R. / Zielinski, C.C. / Hainfellner, J.A. / Liebmann-Reindl, S. / Popitsch, N. / Geier, C.B. / Streubel, B. et al. | 2015
- 1812
-
Hypocalcaemia in patients with metastatic bone disease treated with denosumabBody, Jean-Jacques / Bone, Henry G. / de Boer, Richard H. / Stopeck, Alison / Van Poznak, Catherine / Damião, Ronaldo / Fizazi, Karim / Henry, David H. / Ibrahim, Toni / Lipton, Allan et al. | 2015
- 1822
-
Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimensRocha, L.B. / Gomes-da-Silva, L.C. / Dabrowski, J.M. / Arnaut, L.G. et al. | 2015
- 1831
-
Molecular changes in endometriosis-associated ovarian clear cell carcinomaWorley, Michael J. / Liu, Shubai / Hua, Yuanyuan / Kwok, Jamie Sui-Lam / Samuel, Anicka / Hou, Lei / Shoni, Melina / Lu, Shi / Sandberg, Evelien M. / Keryan, Anna et al. | 2015
- 1843
-
Differences in cancer drug assessment between Spain and the United KingdomLozano-Blazquez, A. / Dickson, R. / Fraga-Fuentes, M.D. / Martinez-Martinez, F. / Calleja-Hernandez, M.A. et al. | 2015
- 1853
-
PD-L1 expression in small cell lung cancerKomiya, T. / Madan, R. et al. | 2015
- 1857
-
^9^0Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesPicozzi, V.J. / Ramanathan, R.K. / Lowery, M.A. / Ocean, A.J. / Mitchel, E.P. / O'Neil, B.H. / Guarino, M.J. / Conkling, P.R. / Cohen, S.J. et al. | 2015
- 1865
-
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumoursPiha-Paul, S.A. / Munster, P.N. / Hollebecque, A. / Argilés, G. / Dajani, O. / Cheng, J.D. / Wang, R. / Swift, A. / Tosolini, A. / Gupta, S. et al. | 2015
- 1874
-
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancerFarolfi, A. / Scarpi, E. / Rocca, A. / Mangia, A. / Biglia, N. / Gianni, L. / Tienghi, A. / Valerio, M.R. / Gasparini, G. et al. | 2015
- 1882
-
MRI and intraoperative pathology to predict nipple-areola complex (NAC) involvement in patients undergoing NAC-sparing mastectomyPonzone, R. / Maggiorotto, F. / Carabalona, S. / Rivolin, A. / Pisacane, A. / Kubatzki, F. / Renditore, S. / Carlucci, S. / Sgandurra, P. et al. | 2015
- 1890
-
Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitorsBrier, Moriah J. / Chambless, Dianne / Gross, Robert / Su, H. Irene / DeMichele, Angela / Mao, Jun J. et al. | 2015
- 1897
-
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsRakha, E. / Pajares, M.J. / Ilie, M. / Pio, R. / Echeveste, J. / Hughes, E. / Soomro, I. / Long, E. / Idoate, M.A. et al. | 2015
- 1904
-
A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911Yamada, K. / Aono, H. / Hosomi, Y. / Okamoto, H. / Kato, T. / Komase, Y. / Nishikawa, M. / Azuma, K. / Takeoka, H. et al. | 2015
- 1911
-
PanGen-Fam: Spanish registry of hereditary pancreatic cancerMocci, E. / Guillen-Ponce, C. / Earl, J. / Marquez, M. / Solera, J. / Salazar-Lopez, M.T. / Calcedo-Arnaiz, C. / Vazquez-Sequeiros, E. / Montans, J. et al. | 2015
- 1918
-
Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancerSylvie, L. / Silvia, S. / Salah-Eddin, A.B. / Markus, F. / Florian, L. / Peter, T.P. / Bernhard, H. / Martin, A. / Alexander, N. et al. | 2015
- 1927
-
Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)Heinemann, V. / Stintzing, S. / Modest, D.P. / Giessen-Jung, C. / Michl, M. / Mansmann, U.R. et al. | 2015
- 1937
-
Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic targetGo, H. / Kim, P.J. / Jeon, Y.K. / Cho, Y.M. / Kim, K. / Park, B.H. / Ku, J.Y. et al. | 2015
- 1946
-
Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancerLoriot, Yohann / Eymard, Jean-Christophe / Patrikidou, Anna / Ileana, Ecaterina / Massard, Christophe / Albiges, Laurence / Di Palma, Mario / Escudier, Bernard / Fizazi, Karim et al. | 2015
- 1953
-
CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinomaAn, H. / Xu, L. / Chang, Y. / Zhu, Y. / Yang, Y. / Chen, L. / Lin, Z. / Xu, J. et al. | 2015
- 1962
-
SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapyShiota, M. / Fujimoto, N. / Yokomizo, A. / Takeuchi, A. / Itsumi, M. / Inokuchi, J. / Tatsugami, K. / Uchiumi, T. / Naito, S. et al. | 2015
- 1970
-
The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancerIacovelli, R. / Verri, E. / Cossu Rocca, M. / Aurilio, G. / Cullura, D. / De Cobelli, O. / Nole, F. et al. | 2015
- 1978
-
Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinomaMatsuo, K. / Hasegawa, K. / Yoshino, K. / Murakami, R. / Hisamatsu, T. / Stone, R.L. / Previs, R.A. / Hansen, J.M. / Ikeda, Y. et al. | 2015
- 1989
-
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineEuropean Dermatology Forum (EDF) / European Association of Dermato-Oncology (EADO) / European Organization for Research and Treatment of Cancer (EORTC) / Stratigos, A. / Garbe, C. / Lebbe, C. / Malvehy, J. / del Marmol, V. / Pehamberger, H. et al. | 2015
- 2008
-
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemiaStumpel, D.J.P.M. / Schneider, P. / Pieters, R. / Stam, R.W. et al. | 2015
- 2022
-
Carboplatin therapeutic monitoring in preterm and full-term neonatesVeal, Gareth J. / Errington, Julie / Hayden, James / Hobin, David / Murphy, Dermot / Dommett, Rachel M. / Tweddle, Deborah A. / Jenkinson, Helen / Picton, Susan et al. | 2015
- 2031
-
Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trialSchoot, R.A. / van Ommen, C.H. / Stijnen, T. / Tissing, W.J.E. / Michiels, E. / Abbink, F.C.H. / Raphael, M.F. / Heij, H.A. / Lieverst, J.A. et al. | 2015
- 2039
-
Trends in survival for teenagers and young adults with cancer in the UK 1992–2006O'Hara, C. / Moran, A. / Whelan, J.S. / Hough, R.E. / Stiller, C.A. / Stevens, M.C.G. / Stark, D.P. / Feltbower, R.G. / McCabe, M.G. et al. | 2015
- 2049
-
Unmet needs and depression among carers of people newly diagnosed with cancerHeckel, L. / Fennell, K.M. / Reynolds, J. / Osborne, R.H. / Chirgwin, J. / Botti, M. / Ashley, D.M. / Livingston, P.M. et al. | 2015
- 2058
-
A review of breast cancer awareness among women in India: Cancer literate or awareness deficit?Gupta, A. / Shridhar, K. / Dhillon, P.K. et al. | 2015
- 2067
-
Similar anatomical distributions of childhood naevi and cutaneous melanoma in young adults residing in northern and southern SwedenKarlsson, Maria A. / Rodvall, Ylva / Wahlgren, Carl-Fredrik / Wiklund, Kerstin / Lindelöf, Bernt et al. | 2015
- 2076
-
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemiaPereira, J.K.N. / Machado-Neto, J.A. / Lopes, M.R. / Morini, B.C. / Traina, F. / Costa, F.F. / Saad, S.T.O. / Favaro, P. et al. | 2015
- 2086
-
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumabValpione, S. / Martinoli, C. / Fava, P. / Mocellin, S. / Campana, L.G. / Quaglino, P. / Ferrucci, P.F. / Pigozzo, J. / Astrua, C. / Testori, A. et al. | 2015
- 2095
-
Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950–7van Rossum, Peter S.N. / Goense, Lucas / van Hillegersberg, Richard / Ruurda, Jelle P. et al. | 2015
- 2095
-
Comment on: Holscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7van Rossum, P.S.N. / Goense, L. / van Hillegersberg, R. / Ruurda, J.P. et al. | 2015
- 2097
-
Reply to the Comment on: Holscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7Bollschweiler, E. / Holscher, A.H. et al. | 2015
- 2097
-
Reply to the Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950–7Bollschweiler, Elfriede / Hölscher, Arnulf H. et al. | 2015
- 2099
-
Tribute to Arduino VerdecchiaRoberta, De Angelis et al. | 2015
- 2101
-
Cancer survival in Europe, 1999–2007: Doing better, feeling worse?Sant, Milena / Minicozzi, Pamela / Primic-Žakelj, Maja / Otter, Renee / Francisci, Silvia / Gatta, Gemma / Berrino, Franco / De Angelis, Roberta et al. | 2015
- 2104
-
The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methodsRossi, Silvia / Baili, Paolo / Capocaccia, Riccardo / Caldora, Massimiliano / Carrani, Eugenio / Minicozzi, Pamela / Pierannunzio, Daniela / Santaquilani, Mariano / Trama, Annalisa / Allemani, Claudia et al. | 2015
- 2120
-
Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based studyBaili, Paolo / Di Salvo, Francesca / Marcos-Gragera, Rafael / Siesling, Sabine / Mallone, Sandra / Santaquilani, Mariano / Micheli, Andrea / Lillini, Roberto / Francisci, Silvia et al. | 2015
- 2130
-
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based studyGatta, Gemma / Botta, Laura / Sánchez, María José / Anderson, Lesley Ann / Pierannunzio, Daniela / Licitra, Lisa et al. | 2015
- 2144
-
Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5Anderson, L.A. / Tavilla, A. / Brenner, H. / Luttmann, S. / Navarro, C. / Gavin, A.T. / Holleczek, B. / Johnston, B.T. / Cook, M.B. / Bannon, F. et al. | 2015
- 2158
-
On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 studyHolleczek, Bernd / Rossi, Silvia / Domenic, Agius / Innos, Kaire / Minicozzi, Pamela / Francisci, Silvia / Hackl, Monika / Eisemann, Nora / Brenner, Hermann et al. | 2015
- 2169
-
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5Lepage, Côme / Capocaccia, Riccardo / Hackl, Monika / Lemmens, Valerie / Molina, Esther / Pierannunzio, Daniela / Sant, Milena / Trama, Annalisa / Faivre, Jean et al. | 2015
- 2179
-
Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 studyCrocetti, Emanuele / Mallone, Sandra / Robsahm, Trude Eid / Gavin, Anna / Agius, Domenic / Ardanaz, Eva / Lopez, Maria-Dolores Chirlaque / Innos, Kaire / Minicozzi, Pamela / Borgognoni, Lorenzo et al. | 2015
- 2191
-
Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 studySant, Milena / Chirlaque Lopez, Maria Dolores / Agresti, Roberto / Sánchez Pérez, Maria José / Holleczek, Bernd / Bielska-Lasota, Magdalena / Dimitrova, Nadya / Innos, Kaire / Katalinic, Alexander / Langseth, Hilde et al. | 2015
- 2206
-
Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 studyTrama, Annalisa / Foschi, Roberto / Larrañaga, Nerea / Sant, Milena / Fuentes-Raspall, Rafael / Serraino, Diego / Tavilla, Andrea / Van Eycken, Liesbet / Nicolai, Nicola et al. | 2015
- 2217
-
Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5Marcos-Gragera, Rafael / Mallone, Sandra / Kiemeney, Lambertus A. / Vilardell, Loreto / Malats, Núria / Allory, Yves / Sant, Milena et al. | 2015
- 2231
-
Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 studyVisser, Otto / Ardanaz, Eva / Botta, Laura / Sant, Milena / Tavilla, Andrea / Minicozzi, Pamela et al. | 2015
- 2242
-
Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 studyFrancisci, Silvia / Minicozzi, Pamela / Pierannunzio, Daniela / Ardanaz, Eva / Eberle, Andrea / Grimsrud, Tom K. / Knijn, Arnold / Pastorino, Ugo / Salmerón, Diego / Trama, Annalisa et al. | 2015
- 2254
-
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based studyDe Angelis, Roberta / Minicozzi, Pamela / Sant, Milena / Dal Maso, Luigino / Brewster, David H. / Osca-Gelis, Gemma / Visser, Otto / Maynadié, Marc / Marcos-Gragera, Rafael / Troussard, Xavier et al. | 2015
- 2269
-
The role of censoring on progression free survival: Oncologist discretion advisedPrasad, Vinay / Bilal, Usama et al. | 2015
- 2272
-
Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: A good thing?Prasad, Vinay et al. | 2015
- 2275
-
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumoursSuder, A. / Ang, J.E. / Kyle, F. / Harris, D. / Rudman, S. / Kristeleit, R. / Solca, F. / Uttenreuther-Fischer, M. / Pemberton, K. / Pelling, K. et al. | 2015
- 2285
-
Optimal breast cancer pathology manifestoTot, T. / Viale, G. / Rutgers, E. / Bergsten-Nordström, E. / Costa, A. et al. | 2015
- 2289
-
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in ItalySilvestri, Valentina / Rizzolo, Piera / Scarnò, Marco / Chillemi, Giovanni / Navazio, Anna Sara / Valentini, Virginia / Zelli, Veronica / Zanna, Ines / Saieva, Calogero / Masala, Giovanna et al. | 2015
- 2296
-
Addressing overtreatment of screen detected DCIS; the LORIS trialFrancis, Adele / Thomas, Jeremy / Fallowfield, Lesley / Wallis, Matthew / Bartlett, John M.S. / Brookes, Cassandra / Roberts, Tracy / Pirrie, Sarah / Gaunt, Claire / Young, Jennie et al. | 2015
- 2304
-
Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapyAlkner, Sara / Ehinger, Anna / Bendahl, Pär-Ola / Rydén, Lisa / Fernö, Mårten et al. | 2015
- 2314
-
Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysisYamaguchi, Norihiro / Fujii, Takeo / Aoi, Shunsuke / Kozuch, Peter S. / Hortobagyi, Gabriel N. / Blum, Ronald H. et al. | 2015
- 2321
-
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerGiaccone, G. / Bazhenova, L.A. / Nemunaitis, J. / Tan, M. / Juhász, E. / Ramlau, R. / van den Heuvel, M.M. / Lal, R. / Kloecker, G.H / Eaton, K.D. et al. | 2015
- 2330
-
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: Results by performance status, EGFR mutation, histology and response to previous inductionTan, Pui San / Lopes, Gilberto / Acharyya, Sanchalika / Bilger, Marcel / Haaland, Benjamin et al. | 2015
- 2345
-
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancerWolff, Robert F. / Ryder, Steve / Bossi, Alberto / Briganti, Alberto / Crook, Juanita / Henry, Ann / Karnes, Jeffrey / Potters, Louis / de Reijke, Theo / Stone, Nelson et al. | 2015
- 2368
-
Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: Results of a pooled analysis of non-interventional studiesAlbiges, Laurence / Kube, Ulrich / Eymard, Jean-Christophe / Schmidinger, Manuela / Bamias, Aristotelis / Kelkouli, Nadia / Mraz, Bernhard / Florini, Styliani / Guderian, Gernot / Cattaneo, Agnese et al. | 2015
- 2375
-
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trialsVerdoodt, F. / Jentschke, M. / Hillemanns, P. / Racey, C.S. / Snijders, P.J.F. / Arbyn, M. et al. | 2015
- 2386
-
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal typeMichot, Jean-Marie / Mazeron, Renaud / Danu, Alina / Lazarovici, Julien / Ghez, David / Antosikova, Anna / Willekens, Christophe / Chamseddine, Ali N. / Minard, Veronique / Dartigues, Peggy et al. | 2015
- 2396
-
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guidelineLebbe, Celeste / Becker, Jürgen C. / Grob, Jean-Jacques / Malvehy, Josep / del Marmol, Veronique / Pehamberger, Hubert / Peris, Ketty / Saiag, Philippe / Middleton, Mark R. / Bastholt, Lars et al. | 2015
- 2404
-
Uveal Melanoma UK National GuidelinesNathan, P. / Cohen, V. / Coupland, S. / Curtis, K. / Damato, B. / Evans, J. / Fenwick, S. / Kirkpatrick, L. / Li, O. / Marshall, E. et al. | 2015
- 2413
-
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomasGounder, Mrinal / Desai, Ved / Kuk, Deborah / Agaram, Narasimhan / Arcila, Maria / Durham, Benjamin / Keohan, Mary L. / Dickson, Mark A. / D'Angelo, Sandra P. / Shukla, Neerav et al. | 2015
- 2423
-
The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal TumoursBarrios, Carlos H. / Blackstein, Martin E. / Blay, Jean-Yves / Casali, Paolo G. / Chacon, Matias / Gu, Jin / Kang, Yoon-Koo / Nishida, Toshirou / Purkayastha, Das / Woodman, Richard C. et al. | 2015
- 2434
-
Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocolvon Bueren, André O. / Friedrich, Carsten / von Hoff, Katja / Kwiecien, Robert / Müller, Klaus / Pietsch, Torsten / Warmuth-Metz, Monika / Hau, Peter / Benesch, Martin / Kuehl, Joachim et al. | 2015
- 2444
-
Thymoma and thymic carcinoma in children and adolescents: A report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT)Stachowicz-Stencel, Teresa / Orbach, Daniel / Brecht, Ines / Schneider, Dominik / Bien, Ewa / Synakiewicz, Anna / Rod, Julien / Ferrari, Andrea / Cecchetto, Giovanni / Bisogno, Gianni et al. | 2015
- 2453
-
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trialvan den Berg, Henk / Paulussen, Michael / Le Teuff, Gwénaël / Judson, Ian / Gelderblom, Hans / Dirksen, Uta / Brennan, Bernadette / Whelan, Jeremy / Ladenstein, Ruth Lydia / Marec-Berard, Perrine et al. | 2015
- 2465
-
Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)Zhou, Margaret J. / Doral, Michelle Y. / DuBois, Steven G. / Villablanca, Judith G. / Yanik, Gregory A. / Matthay, Katherine K. et al. | 2015
- 2473
-
Low cancer suspicion following experience of a cancer 'warning sign'Whitaker, Katriina L. / Winstanley, Kelly / Macleod, Una / Scott, Suzanne E. / Wardle, Jane et al. | 2015
- 2480
-
Potent effect of adenoviral vector expressing short hairpin RNA targeting ribonucleotide reductase large subunit M1 on cell viability and chemotherapeutic sensitivity to gemcitabine in non-small cell lung cancer cellsTokunaga, Yoshimasa / Liu, Dage / Nakano, Jun / Zhang, Xia / Nii, Kazuhito / Go, Tetsuhiko / Huang, Cheng-long / Yokomise, Hiroyasu et al. | 2015
- 2491
-
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)Biganzoli, L. / Lichtman, S. / Michel, J.-P. / Papamichael, D. / Quoix, E. / Walko, C. / Aapro, M. et al. | 2015
- 2501
-
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcomeMonzon, Jose G. / Hay, Annette E. / McDonald, Gail T. / Pater, Joseph L. / Meyer, Ralph M. / Chen, Eric / Chen, Bingshu E. / Dancey, Janet E. et al. | 2015
- 2508
-
Survival of breast cancer patients with synchronous or metachronous central nervous system metastasesHo, V.K.Y. / Gijtenbeek, J.M.M. / Brandsma, D. / Beerepoot, L.V. / Sonke, G.S. / van der Heiden-van der Loo, M. et al. | 2015
- 2517
-
Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapyde Azambuja, Evandro / Ameye, Lieveke / Diaz, Marie / Vandenbossche, Sandrine / Aftimos, Philippe / Hernández, Sara Bejarano / Shih-Li, Chao / Delhaye, François / Focan, Christian / Cornez, Nathalie et al. | 2015
- 2525
-
Improved inter-observer agreement of an expert review panel in an oncology treatment trial – Insights from a structured interventional processNestle, Ursula / Rischke, Hans Christian / Eschmann, Susanne Martina / Holl, Gabriele / Tosch, Marco / Miederer, Matthias / Plotkin, Michail / Essler, Markus / Puskas, Cornelia / Schimek-Jasch, Tanja et al. | 2015
- 2534
-
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based studyHendriks, L.E. / Derks, J.L. / Postmus, P.E. / Damhuis, R.A. / Houben, R.M.A. / Troost, E.G.C. / Hochstenbag, M.M. / Smit, E.F. / Dingemans, A.-M.C. et al. | 2015
- 2545
-
18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patientsElimova, Elena / Wang, Xuemei / Etchebehere, Elba / Shiozaki, Hironori / Shimodaira, Yusuke / Wadhwa, Roopma / Planjery, Venkatram / Charalampakis, Nikolaos / Blum, Mariela A. / Hofstetter, Wayne et al. | 2015
- 2553
-
Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancerBos, A.C.R.K. / van Erning, F.N. / van Gestel, Y.R.B.M. / Creemers, G.J.M. / Punt, C.J.A. / van Oijen, M.G.H. / Lemmens, V.E.P.P. et al. | 2015
- 2562
-
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancervan Soest, R.J. / Nieuweboer, A.J.M. / de Morrée, E.S. / Chitu, D. / Bergman, A.M. / Goey, S.H. / Bos, M.M. / van der Meer, N. / Hamberg, P. / de Wit, R. et al. | 2015
- 2570
-
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy settingAntoun, Sami / Bayar, Amine / Ileana, Ekatarina / Laplanche, Agnès / Fizazi, Karim / di Palma, Mario / Escudier, Bernard / Albiges, Laurence / Massard, Christophe / Loriot, Yohann et al. | 2015
- 2578
-
Tyrosine kinase inhibitors in renal cell cancer: Losing an empire and yet to find a roleEisen, Tim et al. | 2015
- 2580
-
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinomaAlbiges, Laurence / Fay, André P. / Xie, Wanling / Krajewski, Katherine / McDermott, David F. / Heng, Daniel Y.C. / Dariane, Charles / DeVelasco, Guillermo / Lester, Renee / Escudier, Bernard et al. | 2015
- 2587
-
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-upZhang, Meng-Xia / Li, Jing / Shen, Guo-Ping / Zou, Xiong / Xu, Jun-Jie / Jiang, Rou / You, Rui / Hua, Yi-Jun / Sun, Ying / Ma, Jun et al. | 2015
- 2596
-
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysisMarta, Gustavo N. / Riera, Rachel / Bossi, Paolo / Zhong, Lai-ping / Licitra, Lisa / Macedo, Cristiane R. / de Castro, Gilberto / Carvalho, André L. / William, William N. / Kowalski, Luis Paulo et al. | 2015
- 2604
-
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guidelineSaiag, Philippe / Grob, Jean-Jacques / Lebbe, Celeste / Malvehy, Josep / del Marmol, Veronique / Pehamberger, Hubert / Peris, Ketty / Stratigos, Alexander / Middelton, Mark / Basholt, Lars et al. | 2015
- 2609
-
Imatinib in advanced chordoma: A retrospective case series analysisHindi, Nadia / Casali, Paolo G. / Morosi, Carlo / Messina, Antonella / Palassini, Elena / Pilotti, Silvana / Tamborini, Elena / Radaelli, Stefano / Gronchi, Alessandro / Stacchiotti, Silvia et al. | 2015
- 2615
-
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trialsDuffaud, F. / Sleijfer, S. / Litière, S. / Ray-Coquard, I. / Le Cesne, A. / Papai, Z. / Judson, I. / Schöffski, P. / Chawla, S.P. / Dewji, R. et al. | 2015
- 2624
-
CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patientsSand, L.G.L. / Scotlandi, K. / Berghuis, D. / Snaar-Jagalska, B.E. / Picci, P. / Schmidt, T. / Szuhai, K. / Hogendoorn, P.C.W. et al. | 2015
- 2634
-
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacyPompe, Raisa S. / von Bueren, André O. / Mynarek, Martin / von Hoff, Katja / Friedrich, Carsten / Kwiecien, Robert / Treulieb, Wiebke / Lindow, Christine / Deinlein, Frank / Fleischhack, Gudrun et al. | 2015
- 2643
-
Survival patterns in teenagers and young adults with cancer in the United Kingdom: Comparisons with younger and older age groupsStark, Dan / Bowen, David / Dunwoodie, Elaine / Feltbower, Richard / Johnson, Rod / Moran, Anthony / Stiller, Charles / O'Hara, Catherine et al. | 2015
- 2655
-
Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?Boursi, Ben / Mamtani, Ronac / Haynes, Kevin / Yang, Yu-Xiao et al. | 2015
- 2665
-
Childhood central nervous system tumour mortality and survival in Southern and Eastern Europe (1983–2014): Gaps persist across 14 cancer registriesKaralexi, Maria A. / Papathoma, Paraskevi / Thomopoulos, Thomas P. / Ryzhov, Anton / Zborovskaya, Anna / Dimitrova, Nadya / Zivkovic, Snezana / Eser, Sultan / Antunes, Luís / Sekerija, Mario et al. | 2015
- 2678
-
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapySpindler, Karen-Lise Garm / Pallisgaard, Niels / Appelt, Ane Lindegaard / Andersen, Rikke Fredslund / Schou, Jakob V. / Nielsen, Dorte / Pfeiffer, Per / Yilmaz, Mette / Johansen, Julia S. / Hoegdall, Estrid V. et al. | 2015
- 2686
-
How should we use anti-CTLA-4 antibodies?Marabelle, Aurélien / Eggermont, Alexander et al. | 2015
- 2689
-
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumabEroglu, Zeynep / Kim, Dae Won / Wang, Xiaoyan / Camacho, Luis H. / Chmielowski, Bartosz / Seja, Elizabeth / Villanueva, Arturo / Ruchalski, Kathleen / Glaspy, John A. / Kim, Kevin B. et al. | 2015
- 2698
-
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areasKim, Sehui / Kim, Moon-Young / Koh, Jaemoon / Go, Heounjeong / Lee, Dong Soo / Jeon, Yoon Kyung / Chung, Doo Hyun et al. | 2015
- 2708
-
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983Tanis, Erik / Julié, Catherine / Emile, Jean-Francois / Mauer, Murielle / Nordlinger, Bernard / Aust, Daniela / Roth, Arnaud / Lutz, Manfred P. / Gruenberger, Thomas / Wrba, Fritz et al. | 2015
- 2718
-
Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.govPrasad, Vinay / Goldstein, Jeffery A. et al. | 2015
- 2725
-
A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibitionZucchini, G. / Armstrong, A.C. / Wardley, A.M. / Wilson, G. / Misra, V. / Seif, M. / Ryder, W.D. / Cope, J. / Blowers, E. / Howell, A. et al. | 2015
- 2732
-
The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncologyBarton, Sarah / Peckitt, Clare / Sclafani, Francesco / Cunningham, David / Chau, Ian et al. | 2015
- 2740
-
Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancerLeon, Otilia / Guren, Marianne G. / Radu, Calin / Gunnlaugsson, Adalsteinn / Johnsson, Anders et al. | 2015
- 2747
-
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysisHernandez, Adrian V. / Pasupuleti, Vinay / Benites-Zapata, Vicente A. / Thota, Priyaleela / Deshpande, Abhishek / Perez-Lopez, Faustino R. et al. | 2015
- 2759
-
Human papillomavirus genotype and oropharynx cancer survival in the United States of AmericaGoodman, Marc T. / Saraiya, Mona / Thompson, Trevor D. / Steinau, Martin / Hernandez, Brenda Y. / Lynch, Charles F. / Lyu, Christopher W. / Wilkinson, Edward J. / Tucker, Thomas / Copeland, Glenn et al. | 2015
- 2768
-
Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative studyGanly, Ian / Amit, Moran / Kou, Lei / Palmer, Frank L. / Migliacci, Jocelyn / Katabi, Nora / Yu, Changhong / Kattan, Michael W. / Binenbaum, Yoav / Sharma, Kanika et al. | 2015
- 2777
-
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancerSchilling, Clare / Stoeckli, Sandro J. / Haerle, Stephan K. / Broglie, Martina A. / Huber, Gerhard F. / Sorensen, Jens Ahm / Bakholdt, Vivi / Krogdahl, Annelise / von Buchwald, Christian / Bilde, Anders et al. | 2015
- 2785
-
Prognostic score for patients with advanced melanoma treated with ipilimumabDiem, Stefan / Kasenda, Benjamin / Martin-Liberal, Juan / Lee, Alexander / Chauhan, Dharmisha / Gore, Martin / Larkin, James et al. | 2015
- 2792
-
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsJohnson, Douglas B. / Menzies, Alexander M. / Zimmer, Lisa / Eroglu, Zeynep / Ye, Fei / Zhao, Shilin / Rizos, Helen / Sucker, Antje / Scolyer, Richard A. / Gutzmer, Ralf et al. | 2015
- 2800
-
Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosisFiore, Marco / Colombo, Chiara / Radaelli, Stefano / Callegaro, Dario / Palassini, Elena / Barisella, Marta / Morosi, Carlo / Baldi, Giacomo G. / Stacchiotti, Silvia / Casali, Paolo G. et al. | 2015
- 2808
-
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsQuinten, Chantal / Coens, Corneel / Ghislain, Irina / Zikos, Efstathios / Sprangers, Mirjam A.G. / Ringash, Jolie / Martinelli, Francesca / Ediebah, Divine E. / Maringwa, John / Reeve, Bryce B. et al. | 2015
- 2820
-
Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studiesFang, Xuexian / Wei, Jiayu / He, Xuyan / An, Peng / Wang, Hao / Jiang, Li / Shao, Dandan / Liang, Han / Li, Yi / Wang, Fudi et al. | 2015
- 2833
-
Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?van der Leest, Robert J.T. / Zoutendijk, Judith / Nijsten, Tamar / Mooi, Wolter J. / van der Rhee, Jasper I. / de Vries, Esther / Hollestein, Loes M. et al. | 2015
- e1
-
OP0003 Feasibility and efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer: A randomised trialAhmed, B.M. / Wani, K.A. / Wani, M. et al. | 2015
- e2
-
OP0009 Comparison of two fractionation schedules on quality of life and survival in patients with brain metastases: A randomised, double-blind trialSuresh Kumar, K. / Arun, P. et al. | 2015
- e4
-
OP0015 Polymorphisms in apoptosis-related genes and risk of HPV-mediated cervical cancer: A case-control studyAnkathil, R. / Tan, S.C. et al. | 2015
- e5
-
P0007 High-grade T1 bladder urothelial carcinoma: Optimal managementNassir, A. et al. | 2015
- e6
-
P0017 S100P regulates cytoskeleton dynamics to promote cell migration and metastasisDu, M. / Wang, G. / Barraclough, R. / Rudland, P. et al. | 2015
- e8
-
P0028 Isoliquiritigenin causes DNA damage and inhibits ATM expression in oral squamous cell carcinomaShieh, T.M. / Huang, Y.T. / Yu, C.C. / Hsia, S.M. / Shih, Y.H. / Wang, T.H. et al. | 2015
- e10
-
P0034 Pentafecta outcomes plus evaluation of immediate continence after robotic, extraperitoneal, radical prostatectomy with complete preservation of the Veil of AphroditeBoni, A. / Cochetti, G. / Barillaro, F. / Emanuele, C. / Lepri, E. / Mearini, E. et al. | 2015
- e12
-
P0053 Protease-activated receptor-2 in regulation of proliferation and invasion of oral squamous cell carcinoma cellsCheng, J. / Al-Eryani, K. / Abe, T. / Maruyama, S. / Yamazaki, M. / Babkair, H. / Saku, T. et al. | 2015
- e13
-
P0059 Effect of AT-101 and cisplatin on apoptosis in human non-small-cell lung cancer cells: Inhibition of APE1-activated IL-6STAT3 signalling pathwayRen, T. / Wang, D. et al. | 2015
- e14
-
P0066 Pretreatment serum carcinoembryonic antigen levels are associated with chemoradiation-induced downstaging and downsizing of rectal cancerKim, M.J. / Kim, E.S. / Min, C.K. / Yeo, S.G. et al. | 2015
- e15
-
P0073 Clinical characteristics of prostate cancer at a tertiary care medical centre in southern India over 11years: A retrospective analysisSinghal, U. / Chawla, A.K. / Thomas, J. / Hegde, P. et al. | 2015
- e16
-
P0078 Postoperative morbidity and mortality following D2 gastrectomy: An audit of 456 patientsSunil, B.J. / Seshadri, R.A. et al. | 2015
- e17
-
P0089 Prognostic factors for node-positive breast cancer after surgery, chemotherapy, and radiotherapyLiang, C.C. / Pi, C.P. et al. | 2015
- e18
-
P0094 Tumour budding in oral squamous cell carcinomas as a prognostic factorAttramadal, C.G. / Kumar, S. / Dhakal, H.P. / Boysen, M.E. / Nesland, J.M. / Bryne, M. et al. | 2015
- e21
-
P0108 Analysis of cytotoxic effects of selected smokeless tobacco productsJose, M. / Varghese, I. / Shantaram, M. et al. | 2015
- e23
-
P0115 Effect of differential stage or treatment on socioeconomic inequalities in survival from non-small-cell lung carcinoma (NSCLC): Mediation analysis using Osaka population-based cancer registry data in JapanRachet, B. / Ito, Y. / Li, R. / Ioka, A. / Nakayama, T. et al. | 2015
- e25
-
P0122 The unique pathological characteristics and prognostic significance of primary lung adenocarcinoma of 1cm or less in sizeZhang, Y.K. / Zhu, W.Y. / Wang, Z.Y. / Wang, S.J. / Zhou, K.Y. / Tan, L.L. / Le, H.B. et al. | 2015
- e28
-
P0143 Diagnostic possibilities of an echodopplerography in an assessment of prevalence of a tumoural invasion of a stomach cancerIsamukhamedova, M. / Pulatova, I.Z. et al. | 2015
- e29
-
P0155 Effect of pretreatment anaemia on outcomes of Chinese women with breast cancer receiving neoadjuvant chemotherapyZhu, W. / Xu, B. et al. | 2015
- e32
-
P0170 Trastuzumab for HER2-positive breast cancer: Experience from a middle-income Asian countryHo, G.F. / Mastura, M.Y. / Kaur, R.P. / Hoo, L.P. / Lim, T.O. et al. | 2015
- e33
-
P0175 Patients' perspectives on the current status of cancer pain management in AsiaTho, L.M. / Calimag, M.M.P. / Ahn, J.S. / Chao, T.C. / Ho, K.Y. / Kim, Y.C. / Xia, Z.J. / Ward, L. / Moon, H. et al. | 2015
- e34
-
P0184 Establishment of a cell microencapsulation model using mucoepidermoid carcinoma cellsGuo, L.j. / Pan, X.f. / Yang, S. / Loo, W.T. / C Chow, L.W. / Tsang, W. et al. | 2015
- e35
-
P0193Marsdenia tenacissima extract enhances gefitinib efficacy in non-small-cell lung cancer xenograftsHan, S.Y. / Zhao, W. / Sun, H. / Zhou, N. / Zhou, F. / An, G. / Li, P.P. et al. | 2015
- S1
-
Basic Science/Translational Research| 2015
- S1
-
102 IL-6 receptor antibody enhances the effect of TKI against renal cell carcinomaIshibashi, K. / Kubo, H. / Kojima, Y. / Haber, T. / Thüroff, J.W. / Brenner, W. et al. | 2015
- S2
-
105 Targeting phosphatidylserine-mediated immune suppression enhances the efficacy of immune checkpoint blockade in preclinical tumor models of melanoma and breastHutchins, J. / Freimark, B. / Brekken, R. / Huang, X. et al. | 2015
- S2
-
ITOC2 - 006. Notch triggers myeloid reprogramming in murine pancreatic cancerFlorian, N. / David, K.G. / Dieter, S. / Roland, S.M. / Mathias, H.F. / Jens, S.T. et al. | 2015
- S3
-
Basic Science| 2015
- S3
-
110 Linking glioblastoma multiforme microRNA profiles with a potential susceptibility to dendritic cell-based cancer immunotherapyErhart, F. / Dohnal, A. / Reitermeier, R. / Hack, M. / Hainfellner, J. / Felzmann, T. / Visus, C. et al. | 2015
- S4
-
ITOC2 - 012. Neoadjuvant immune checkpoint blockade for pancreatic cancer prevents local tumour recurrence through tissue resident antitumoural CD8+ CD103+ T cellsJennifer, B. / Bettina, F.M. / Norman, W. / Stefan, K. / Florian, K. / Engin, G. et al. | 2015
- S5
-
ITOC2 - 015. Therapy of hepatocellular carcinoma (HCC) with immunostimulatory RNA activating RIG-ILaura, P. / Igor, L. / Daniel, B. / Stephanie, H. / Stefan, E. / Peter, D. / Simon, R. / Max, S. et al. | 2015
- S6
-
ITOC2 - 017. Prolonged survival for patients with recurrent glioblastoma multiforme who are treated with tumour lysate-pulsed autologous dendritic cellsMarnix, B.L. / Robert, P.M. / Linda, L. et al. | 2015
- S7
-
ITOC2 - 020. VGX-3100 Immunotherapy for CIN23 Induces regression of cervical lesions and viral clearance (Phase II study): Implications for treatment of HPV associated cancersNiranjan, S. / Cornelia, T. / Matthew, M. / Xuefei, S. / Michael, D. / David, W. / Jean, B. / Jian, Y. / Jessica, L. et al. | 2015
- S8
-
128 FTS (Fused Toes Homolog) silencing increases the effect of cisplatin through inhibiting EGFR-mediated repair of DNA damage in cervix cancer cellsPark, W.Y. / Ds, P. / Cinghu, S. / Yu, J.R. et al. | 2015
- S8
-
ITOC2 - 023. Integrated computational pipeline for development of personalised melanoma vaccineTanushree, J. / Shailendra, G.Dr. / Jan, D.Dr. / Julio Vera, G.Pr. / Neils, S.Dr. / Beatrice, S.T.Dr. / Gerold, S.Pr. et al. | 2015
- S9
-
ITOC2 - 026. A new fusion receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapySebastian, K. / Simon, G. / Michael, C. / Christopher, L. / Fabian, K. / Simon, R. / Max, S. / Stefan, E. et al. | 2015
- S10
-
ITOC2 - 029. Combination of CTLA4-blockade, depletion of CD25+ cells and active-specific immunotherapy prolongs survival in murine melanomaJulia, K.R. / Peter, R. / Louis, B. / Rudolf, H.A. / Hauke, W. / Natasja, V.D.E.K. et al. | 2015
- S10
-
135 Nucleosome occupancy and epigenetic modifications in the alternative splicing site of ZNF518B gene in colorectal cancerRiffo-Campos, A.L. / Castillo, J. / Siscar-Lewin, S. / Vallet-Sanchez, A. / Lopez-Rodas, G. / Franco, L. et al. | 2015
- S11
-
139 The role of DOT1L in neuroblastomaWong, M. / Polly, P. / Liu, T. et al. | 2015
- S12
-
143 Evaluation of miR-708-5p expression and its role in osteosarcoma tumorigenesisBrassesco, M. / Delsin, L. / Fedatto, P. / Scrideli, C. / Tone, L. et al. | 2015
- S12
-
ITOC2 - 036. A method for developing predictive tests for immunotherapy benefitHeinrich, R. / Joanna, R. et al. | 2015
- S14
-
150 MicroRNA-199a and 214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumorKuninty, P.R. / Bojmar, L. / Sandström, P. / Storm, G. / Prakash, J. et al. | 2015
- S16
-
158 PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferationSaceda, M. / Fernandez-Ballester, G. / Encinar-Hidalgo, J.A. / Caruana, P. / Poveda-Delltel, M. / Lucero-Calabuig, P. / Garcia-Morales, P. / Martinez-Lacaci, I. et al. | 2015
- S17
-
161 Newly synthesized Zinc/Gold and Zinc/Silver complexes with Schiff-base ligands as potential anticancer agentsAlexandrova, R. / Zhivkova, T. / Abudalleh, A. / Dyakova, L. / Dinev, D. / Mitrenga, P. / Ivanov, D. / Toshkova, R. / Gavrilov, I. / Georgieva, M. et al. | 2015
- S18
-
165 PDL-1 is highly expressed on circulating epithelial tumor cells (CETCs) and could be a crucial factor in the inhibition of immune response to CETCs during metastasis formationPizon, M. / Zimon, D. / Maier, V. / Pachmann, U. / Pachmann, K. et al. | 2015
- S19
-
168 Mesenchymal stem cells protects ovarian cancer cells from chemotherapy through IL6 secretionGosset, M. / Geyl, C. / Mirshahi, M. / Maleki, M. / Rafii, A. / Touboul, C. et al. | 2015
- S20
-
172 Impact of macrophages and age on tumour growth characteristics in a murine ocular tumour modelKilian, M.M. / Pfarrer, C. / Kurts, C. / Holz, F.G. / Löffler, K.U. et al. | 2015
- S23
-
182 Implication of IL-7 in mesothelial paracellular resistance, migration and interaction with colorectal cancer cellsSanders, A. / Owen, S. / Topley, N. / Kift-Morgan, A. / Jiang, W. et al. | 2015
- S24
-
185 Combined proteomics and transcriptomics identifies carboxypeptidase B1 and NF-κB associated proteins as putative biomarkers of metastasis in low grade breast cancerBouchal, P. / Dvořáková, M. / Roumeliotis, T. / Bortlíček, Z. / Ihnatová, I. / Procházková, I. / Ho, J.T.C. / Maryáš, J. / Imrichová, H. / Budinská, E. et al. | 2015
- S25
-
188 Knock down of SOX2, KLF4 and MYC genes increase sensitization to chemotherapeutic drugs and decrease metastasis in prostate cancer stem cellsCastellón, E. / Valenzuela, R. / Cifuentes, F. / Contreras, H. et al. | 2015
- S26
-
191 Potential interactions between Interleukin-20 and Transglutaminase 4 might affect prostate cancer cell functionOwen, S. / Dart, A. / Cui, Y. / Ablin, R. / Mason, M. / Jiang, W.G. et al. | 2015
- S27
-
Translational Research| 2015
- S29
-
208 Different prognostic impact of STK11 mutations in Non-Small-Cell Lung Cancer (NSCLC) illustrates the switch from a tumor suppressor to an oncogenePecuchet, N. / Laurent-Puig, P. / Mansuet-Luppo, A. / Legras, A. / Alifano, M. / Pallier, K. / Didelot, A. / Gibault, L. / Danel, C. / Just, P.A. et al. | 2015
- S30
-
211 Screening for the prevalence of EGFR and ALK mutations in lung adenocarcinoma patients in the levant area, a prospective analysisTfayli, A. / Rafei, H. / Khalil, M. / Mina, A. / Fakhreddin, N. / Mahfouz, R. / Farhat, F. / Rabee, H. / Hamouri, S. / Dbouk, H. et al. | 2015
- S34
-
224 The DETECT study concept - circulating tumor cells (CTCs) in women with advanced breast cancerSchochter, F. / Schramm, A. / Friedl, T.W. / Albrecht, S. / Jäger, B. / Huober, J. / Rack, B. / Trapp, E. / Fasching, P.A. / Taran, F.A. et al. | 2015
- S36
-
229 Hypoxia modulation in Renal Cell Carcinoma by extracellular levels of miR-210 and miR-1233: Implications in time-to-disease progressionDias, F. / Teixeira, A.L. / Ribeiro, B. / Bastos, N. / Fernandes, M. / Sequeira, M.I. / Maurício, J. / Lobo, F. / Klaas, K. / Medeiros, R. et al. | 2015
- S37
-
232 Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncologyLim, H. / Schrader, K. / Young, S. / Fok, A. / Pleasance, E. / Jones, M. / Shen, Y. / Armstrong, L. / Virani, A. / Rassekh, S. et al. | 2015
- S38
-
235 Genomic analyses of circulating tumor DNA in the plasma of neuroblastoma patientsHuetter, S.C. / Walder, D. / Brunner, C. / Ladenstein, R. / Abbasi, M.R. / Ambros, I.M. / Ambros, P.F. et al. | 2015
- S39
-
238 Chromosomal instability in cancer and immune-related genesMadden, S.F. / Collins, D.M. / Gaynor, N. / Gallagher, W.M. / O'Donovan, N. / Crown, J. et al. | 2015
- S41
-
245 Insights on histone deacetylase inhibitors - induced cell death in cancer cell linesSaceda, M. / Castroviejo, N. / Gomez-Martinez, A. / Martinez-Lacaci, I. / Caruana, P. / Ventero, M. / Garcia-Morales, P. et al. | 2015
- S42
-
248 Fibroblast Growth Factor Receptor (FGFR)3 sustains acquired resistance to trastuzumab in gastric cancer patientsPiro, G. / Carbone, C. / Cataldo, I. / Di Nicolantonio, F. / Giacopuzzi, S. / Boschi, F. / Zanotto, M. / Merz, V. / Mina, M.M. / Sbarbati, A. et al. | 2015
- S43
-
252 Intra platelet serotonin and oncological outcomePadickakudy, R. / Haegele, S. / Offensperger, F. / Pereyra, D. / Ohlberger, L. / Assinger, A. / Fleischmann, E. / Brostjan, C. / Gruenberger, T. / Starlinger, P. et al. | 2015
- S44
-
255 Angiogenic effects of low-dose ionizing radiation to peri-tumoral tissueGil Marques, F. / Cardina, C. / Freitas, T. / Mendes de Almeida, J.C. / Pina, F. / Poli, E. / Mareel, M. / Santos, S. Constantino Rosa et al. | 2015
- S45
-
258 Macrocytosis as a potential parameter associated with outcome in the treatment with tyrosine kinase inhibitorsMathijssen, R. / Kloth, J. / Hamberg, P. / Mendelaar, P. / Dulfer, R. / Van der Holt, B. / Wiemer, E. / Kruit, W. / Sleijfer, S. et al. | 2015
- S46
-
261 The insulin-glucose axis in breast cancer - relationship to clinical outcomeGuadagni, F. / Ferroni, P. / Riondino, S. / Laudisi, A. / Portarena, I. / Alessandroni, J. / D'Alessandro, R. / Costarelli, L. / Cavaliere, F. / Buonomo, O. et al. | 2015
- S48
-
267 Molecular profile of 5-fluorouracil pathway genes in colorectal carcinomaKunicka, T. / Prochazka, P. / Krus, I. / Bendova, P. / Protivova, M. / Susova, S. / Hlavac, V. / Liska, V. / Novak, P. / Schneiderova, M. et al. | 2015
- S49
-
270 Differential effects of IGF-1R inhibitors BMS-754807 and OSI-906 in human cancer cell linesSaceda, M. / Poveda-Deltell, M. / Fuentes-Baile, M. / Martinez-Lacaci, I. / Gomez-Martinez, A. / Castroviejo, N. / Encinar-Hidalgo, J.A. / Garcia-Morales, P. et al. | 2015
- S50
-
273 Modelling tumor-stroma crosstalk in vivo by co-implantation of human fibroblasts and human lung cancer cells orthotopically into immuncompromized miceOswald, E. / Espírito Santo, V. / Rudisch, A. / Brito, C. / Sommergruber, W. / Dolznig, H. / Schüler, J. et al. | 2015
- S51
-
276 Delivery of SDF-1α in a matrix-bound manner on cancer cell behaviors: Underlying molecular mechanismsLiu, X. / Dalonneau, F. / Fourel, L. / Sadir, R. / Lortat-Jacob, H. / Albiges-Rizo, C. / Picart, C. et al. | 2015
- S52
-
279 Human liver cancer stem cell resistance to sorafenib and enhanced sensitivity by MK2206 in vitro and in vivoYin, Z. / Zhai, B. / Zhang, X. / Sun, B. / Cao, L. / Zhao, L. / Li, J. / Ge, N. / Chen, L. / Qian, H. et al. | 2015
- S53
-
300 Phase I study of two dosing schedules of the investigational oral pan-RAF kinase inhibitor MLN2480 in patients (pts) with advanced solid tumors or melanomaRasco, D.W. / Middleton, M.R. / Gonzalez, R. / Corrie, P. / Pavlick, A. / Lorigan, P. / Plummer, R. / Gore, M. / Herbert, C. / Agarwala, S.S. et al. | 2015
- S53
-
Early Drug Development| 2015
- S54
-
302 A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumorsItaliano, A. / Keilhack, H. / Toulmonde, M. / Coindre, J.M. / Michot, J.M. / Massard, C. / Ottesen, L. / Reyderman, L. / Blakemore, S.J. / Kraljevic, S. et al. | 2015
- S55
-
304 Vanucizumab reduces vessel permeability, perfusion and cellular density of tumor lesions in cancer patients as measured by DCE-MRI and DW-MRINayak, T. / Massard, C. / Martinez Garcia, M. / Le Tourneau, C. / Boni, V. / Garralda, E. / Taus, A. / Albanell, J. / Lahr, A. / Krieter, O. et al. | 2015
- S56
-
307 Population pharmacokinetic and pharmacodynamic modeling of bevacizumab and a proposed biosimilar (GP2019) in healthy male volunteersElmeliegy, M. / Potocka, E. / Renard, D. / Kakar, S. / Skerjanec, A. / Li, Y. / Castro, H. / Izquierdo, M. / Barker, D. et al. | 2015
- S57
-
309 Study of carrier erythrocyte encapsulated fluorouracil in mice with malignant ascitesLuo, F. / Lu, Z. / Wang, G. / Zhang, N. / Yang, J. / Wu, S. / Yang, L. / Jing, X. et al. | 2015
- S58
-
312 A phase I dose escalation study to assess the safety tolerability and pharmacokinetics of ETS2101 in patients (pts) with advanced solid tumoursPlummer, R. / Anthoney, A. / Evans, J. / Haris, N. / D'Archangelo, M. / Slater, S. / Campbell, S. / Brindley, C. / Self, S. / McKeown, P. et al. | 2015
- S59
-
315 Impact of acid-reducing agents (ARAS) on the pharmacokinetics of palbociclib, a weak base with ph-dependent solubility, under differing food intake conditionsSun, W. / Klamerus, K.J. / Yuhas, L.M. / Pawlak, S. / Plotka, A. / O'Gorman, M. / Kosa, M. / Wang, D. et al. | 2015
- S62
-
324 Dose-seeking phase I trials (DSPT) of approved molecularly targeted therapies (MTT): Exhaustiveness and readability of published clinical reportsCousin, S. / Hollebecque, A. / Isambert, N. / Italiano, A. / Kotecki, N. / Postel-Vinay, S. / Gobbo, J. / Toulmonde, M. / Penel, N. et al. | 2015
- S63
-
328 Cancer cell specific and selective photodynamic therapy using newly developed glucose- and oligosaccharide-conjugated chlorinsKataoka, H. / Hayashi, N. / Kubota, E. / Tanaka, M. / Yano, S. / Sakai, Y. / Joh, T. et al. | 2015
- S64
-
331 Safety profile and anti-tumor activity of a new generated human/mouse cross-reactive anti-claudin-4 monoclonal antibody in miceHashimoto, Y. / Kawahigashi, Y. / Hata, T. / Kimura, Y. / Watari, A. / Kondoh, M. / Yagi, K. et al. | 2015
- S67
-
341 Phase I clinical pharmacokinetics, safety and tolerability of simotinib in advanced NSCLC patients with EGFR mutationHan, X. / Li, N. / Hu, X. / Song, Y. / Zhang, Y. / Shi, Y. et al. | 2015
- S68
-
344 Single agent supoinoxin targeting phosphorylated p-68 preliminary phase 1 dataGluck, W.L. / Eckhardt, S.G. / Gutierrez, M. / Peterson, C. / Benaim, E. et al. | 2015
- S70
-
350 How effective are novel biological therapies? A systematic review of 121 randomized controlled trials (RCTs)Cho, D. / Roncolato, F. / Man, J.J. / Lord, S.J. / Links, M. / Simes, J. / Lee, C.K. et al. | 2015
- S71
-
353 HIF-2 alpha targeting with a novel RNAi delivery platform as therapy for renal cell carcinomaWong, S. / Cheng, W. / Wakefield, D. / Almeida, A. / Blokhin, A. / Almeida, L. / Hamilton, H. / Subbotin, V. / Hegge, J. / Bertin, S. et al. | 2015
- S72
-
355 Targeting the STAT6 pathway to inhibit tumor-associated macrophages-induced tumor growth and metastasis in breast cancerBinnemars-Postma, K. / Bansal, R. / Storm, G. / Prakash, J. et al. | 2015
- S74
-
362 Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)Ejadi, S. / Vogelzang, N. / Sartor, A. / Clark, R. / Tolcher, A. et al. | 2015
- S75
-
365 Identification of the recommended phase II dose (RP2D) of the c-Met Inhibitor tepotinib (MSC2156119J) in Japanese patients (pts) with solid tumors: A phase I trialYamazaki, K. / Tsushima, T. / Shitara, K. / Sarholz, B. / Fujita, M. / Doi, T. et al. | 2015
- S76
-
367 Effects of alisertib (MLN8237), an investigational Aurora A kinase inhibitor (AAKi), on the QTc interval in patients (pts) with advanced malignanciesZhou, X. / Nemunaitis, J. / Pant, S. / Bauer, T.M. / Patel, M. / Sarantopoulos, J. / Lockhart, A.C. / Goodman, D. / Zhang, B. / Ullmann, C. Dansky et al. | 2015
- S78
-
Diagnostic/Biomarkers| 2015
- S78
-
400 Impact of KRAS/NRAS mutation status on the outcomes of patients with stage III colorectal cancer: Correlative study in NSAS-CC/RCSasaki, Y. / Akasu, T. / Saito, N. / Kojima, H. / Matsuda, K. / Nakamori, S. / Komori, K. / Amagai, K. / Yamaguchi, T. / Nagashima, K. et al. | 2015
- S82
-
413 Accuracy of pleural carcinoembryonic antigen (CEA) assay in malignant pleural effusionsBasso, S.M.M. / Tozzoli, R. / Falcomer, F. / Conte, A. Del / Chiara, G.B. / Lumachi, F. et al. | 2015
- S83
-
416 Variant Alleles in Factor V Leiden (FVL), Prothrombin, Plasminogen Activator Inhibitor-1 (PAI-1) or Methylenetetrahydrofolate Reductase (MTHFR) and risk of thromboembolic events (TEE) in metastatic colorectal cancer (mCRC) patientsFalvella, F.S. / Cremolini, C. / Miceli, R. / Nichetti, F. / Cheli, S. / Antoniotti, C. / Infante, G. / Martinetti, A. / Loupakis, F. / Bartolomeo, M. Di et al. | 2015
- S84
-
419 Androgen receptor (AR) and AR-V7 expression in circulating tumor cells (CTCs) and response to prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in castration-resistant prostate cancer: A correlative analysis from a phase 2 trialPetrylak, D.P. / DiPippo, V.A. / Werner, S.L. / Baird, S. / Anderson, A.K.L. / Marrinucci, D. / Israel, R.J. et al. | 2015
- S85
-
422 Our experience with HER2 screening of the bioptic breast cancer samples using the method fluorescence in situ hybridization in the year 2014 - application of the updated ASCO/CAP guideline recommendationsZmolikova, J. / Pitronova, S. / Uvirova, M. / Kubova, B. / Simova, J. / Strossova, N. / Ziak, D. / Dvorackova, J. et al. | 2015
- S86
-
425 Circulating-free DNA analysis in mouse models of early lung cancerTrigg, R. / Rakhit, C. / Giblett, S. / Kelly, M. / Janus, J. / Martins, M. / Shaw, J. / Pritchard, C. et al. | 2015
- S88
-
431 Biomarkers related to Vanucizumab single agent therapy in serial plasma, tumor tissue and skin wound-healing biopsies of patients with advanced solid tumorsBabitzki, G. / Hidalgo, M. / Massard, C. / Garcia, M. Martinez / Tourneau, C. Le / Boni, V. / Mestres, J. Albanell / Garcia, A. Taus / Alt, M. / Sablin, M.P. et al. | 2015
- S89
-
433 Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC)Oudard, S. / Benhamouda, N. / Escudier, B. / Ravel, P. / Kothari, D. / Mehmud, F. / Levionnois, E. / Sevin, E. / Negrier, S. / Barthelemy, P. et al. | 2015
- S90
-
436 The Prospective Epidemiologic Risk Factor (PERF I) Study: A novel prognostic serum biomarker reflecting type I collagen degradation is associated with tumor burdenKehlet, S.N. / Bager, C.L. / Willumsen, N. / Dragsb, K. / Neergaard, J.S. / Hansen, H.B. / Bay-Jensen, A.C. / Oersnes-Leeming, D.J. / Christiansen, C. / Karsdal, M.A. et al. | 2015
- S91
-
439 Expression of the mTOR pathway genes as prognostic factors for distance recurrence free survival in breast cancer treated with neoadjuvant therapyAraujo, J. / Flores, C. / Prado, A. / Pinto, J. / Vallejos, C. / Aguilar, A. et al. | 2015
- S92
-
442 VEGFR, CD, MIB-1 and Bcl-2 expressions as long-term prognostic factors in renal cell cancerVirman, J. / Bono, P. / Luukkaala, T. / Sunela, K. / Kellokumpu-Lehtinen, P.L. / Kujala, P. et al. | 2015
- S93
-
445 Clinical utility of chemotherapy based on the estimated primary organ in patients with cancer of unknown primary siteKodaira, M. / Yonemori, K. / Yoshida, A. / Shimoi, T. / Shimomura, A. / Yunokawa, M. / Shimizu, C. / Fujiwara, Y. / Tamura, K. et al. | 2015